[Note: Links below are original to the email, or article, and it’s very possible they no longer work.]
[Note: Shared for #AutisticHistory archive purposes. This is NOT An Autistic Ally.]
COVID-19 UPDATE: Autism Therapy Market Likely to Experience a Tremendous Growth in Near Future|| Pfizer Inc., Eli Lilly and Company, ALLERGAN, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Johnson & Johnson Services Inc., Aspire Autism LLC
Data Bridge Market Research has added an exhaustive research study of the Global Autism Therapy Market detailing every single market driver and intricately analyzing the business vertical.
Global Autism Therapy Market report brings together a meticulous study of the present and upcoming opportunities to elucidate the future investment in the industry. This report introduces top to bottom evaluation of the industry including empowering technologies, key trends, market drivers, challenges, standardization, regulatory landscape, opportunities, future guide, value chain, ecosystem player profiles and strategies.
This report is a valuable source of assistance for companies and individuals that offers industry chain structure, business strategies and proposals for new project investments.
The credible Global Autism Therapy Market report also analyses various inhibitors as well as motivators of the market in both quantitative and qualitative manners to make available accurate information to the end users.
Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-autism-therapy-market
The Global Autism Therapy Market is set to rise from its initial estimated value of USD 5.62 billion in 2018 to an estimated value of USD 7.85 billion by 2026, registering a CAGR of 4.25% in the forecast period of 2019-2026. This rise in market value can be attributed to the rising awareness about the disease and its prevalence in the market.
An excellent Global Autism Therapy Market report describes complete market analysis with inputs from industry experts. While formulating this global market document, following aspects are kept into view and include market type, organization size, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. The world class market research analysis brings together a vast market place clearly into the focus. The research studies of Global Autism Therapy Market report helps evaluate several important parameters that can be mentioned as investment in a rising market, success of a new product, and expansion of market share.
Key Market Competitors: Global Autism Therapy Market
Few of the competitors currently working in the autism therapy market are
- Pfizer Inc.,
- Eli Lilly and Company,
- Merck & Co. Inc.,
- Teva Pharmaceutical Industries Ltd.,
- Novartis AG,
- Johnson & Johnson Services Inc.,
- Aspire Autism LLC,
- Hopebridge LLC.,
- Bristol-Myers Squibb Company,
- Otsuka Holdings Co.Ltd.,
- Curemark LLC.,
- Sosei Group,
- Sun Pharmaceutical Industries Ltd.,
- Mylan N.V.,
- Endo Pharmaceuticals Inc.,
- F. Hoffmann-La Roche Ltd.
Global Autism Therapy Market, By Type (Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder), By Treatment Type (ABA, Hyperbaric Oxygen Therapy, Chelation Therapy, Oxytocin Therapy, Others), By Drug (Anticonvulsants, Antipsychotics, Insomnia Drugs, SSRIs, Stimulants, Others), By Distribution Channel (Hospital & Clinics, Retail Pharmacies, Online Pharmacies), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends & Forecast to 2026
Autism is a neurological disorder that is associated with a number of disabilities like lack of social skills, challenges with behavior of the individual. The intensity and severity of the disease is different with every individual. Diagnosis of autism can be done from a very young age with kids of age 2-3 year old. The cause is of yet unknown, but constant research and development is being carried on for the complete information of the disease.
Reasons to Purchase this Report:
- Current and future of global autism therapy market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
- Rising prevalence of disease and government initiatives increasing awareness about the disease is expected to drive the market growth
- Increased research and development initiatives and expenditure, is also expected to drive the market growth
- Stringent regulations and approval procedure by the authorities for the treatment, is also expected to act as a restraint to the market growth
- Inability of penetration in developing areas and awareness in those regions is also expected to restrain the market growth
Key Developments in the Market:
- In January 2018, US Food and Drug Administration granted balovaptan; investigational oral medicine for treatment of social interactions in patients with autism disorder, Breakthrough Therapy Designation.
Competitive Analysis: Global Autism Therapy Market
The global autism therapy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of autism therapy market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Grab Your Report at an Impressive 30% Discount! Please click Here@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-autism-therapy-market
Segmentation: Global Autism Therapy Market
- By Type
- Asperger Syndrome
- Pervasive Developmental Disorder
- Autistic Disorder
- By Treatment Type
- Applied Behavioral Analysis (ABA)
- Hyperbaric Oxygen Therapy
- Chelation Therapy
- Oxytocin Therapy
- By Drug
- Abilify (aripiprazole)
- Insomnia Drugs
- By Distribution Channel
- Hospital & Clinics
- Retail Pharmacies
- Online Pharmacies
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid.
ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.
The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t work. In study after repeated study: ABA (conversion therapy) doesn’t work.
What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.
The ‘cure’ for Autistics not born yet is the prevention of birth.
The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome.
This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.
Fact: You can’t cure Autistics from being Autistic.
Fact: You can’t recover an Autistic from being Autistic.
Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.
[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]
Fact: Vaccines Do Not Cause Autism.